ATE194625T1 - Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür - Google Patents

Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür

Info

Publication number
ATE194625T1
ATE194625T1 AT92400496T AT92400496T ATE194625T1 AT E194625 T1 ATE194625 T1 AT E194625T1 AT 92400496 T AT92400496 T AT 92400496T AT 92400496 T AT92400496 T AT 92400496T AT E194625 T1 ATE194625 T1 AT E194625T1
Authority
AT
Austria
Prior art keywords
lmrh
immunoneutralization
peptides
therefor
castrated male
Prior art date
Application number
AT92400496T
Other languages
English (en)
Inventor
Raymond Dufour
Claude Roulet
Claire Chouvet
Michel Bernard Bonneau
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26228546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE194625(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9102513A external-priority patent/FR2673377B1/fr
Priority claimed from FR9115289A external-priority patent/FR2685333B1/fr
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE194625T1 publication Critical patent/ATE194625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92400496T 1991-03-01 1992-02-26 Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür ATE194625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9102513A FR2673377B1 (fr) 1991-03-01 1991-03-01 Procede pour ameliorer les qualites organoleptiques des animaux domestiques non castres.
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Publications (1)

Publication Number Publication Date
ATE194625T1 true ATE194625T1 (de) 2000-07-15

Family

ID=26228546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92400496T ATE194625T1 (de) 1991-03-01 1992-02-26 Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür

Country Status (19)

Country Link
US (1) US5573767A (de)
EP (1) EP0501882B1 (de)
JP (1) JP3177246B2 (de)
KR (1) KR100257214B1 (de)
AT (1) ATE194625T1 (de)
CA (1) CA2081660C (de)
CZ (1) CZ287775B6 (de)
DE (1) DE69231232T2 (de)
DK (1) DK0501882T3 (de)
ES (1) ES2149166T3 (de)
GR (1) GR3034509T3 (de)
HU (1) HU214453B (de)
IE (1) IE920648A1 (de)
PL (1) PL296623A1 (de)
PT (1) PT501882E (de)
SK (1) SK282056B6 (de)
TW (1) TW221674B (de)
UA (1) UA40570C2 (de)
WO (1) WO1992015330A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6761890B1 (en) * 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
CU22627A1 (es) * 1996-12-17 2000-12-22 Ct Ingenieria Genetica Biotech Preparado vacunal para la inmuno-castración reversible de mamíferos
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
CA2327262A1 (en) * 1998-05-05 1999-11-11 Biostar Inc. Methods of raising animals for meat production
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
WO2003089590A2 (en) * 2002-04-16 2003-10-30 Vaxin, Inc. TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
EP2161037A3 (de) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin Konjugaten
JP2005098877A (ja) * 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd 抗体検出体、その製造方法、及び抗体検出方法
KR20080004445A (ko) * 2004-09-10 2008-01-09 더 카운실 오브 더 퀸스랜드 인스티튜트 오브 메디칼 리서어치 절단형 ｌｈｒｈ 포뮬레이션
AR052051A1 (es) 2004-12-15 2007-02-28 Neuralab Ltd Anticuerpos ab humanizados usados en mejorar la cognicion
KR100701550B1 (ko) * 2005-05-24 2007-03-30 한국과학기술연구원 베어링리스 스텝모터
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP5752343B2 (ja) * 2007-01-24 2015-07-22 株式会社ココカラファインネクスト Ｓ／ｏ型経皮免疫剤
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
JP5889529B2 (ja) 2007-07-27 2016-03-22 ヤンセン・サイエンシズ・アイルランド・ユーシー アミロイド原性疾患の処置
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
ES2674439T3 (es) 2011-06-01 2018-06-29 Merial, Inc. Administración sin aguja de vacunas contra el VSRRP
KR20150100651A (ko) * 2012-10-30 2015-09-02 리컴비네틱스 인코포레이티드 동물의 성적 성숙 조절

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
JPH01500663A (ja) * 1986-08-18 1989-03-09 バンジ・（オーストラリア）・プロプライアタリー・リミテッド 動物の生殖機能の調節
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs

Also Published As

Publication number Publication date
TW221674B (de) 1994-03-11
HU9203419D0 (en) 1993-01-28
CZ287775B6 (cs) 2001-01-17
ES2149166T3 (es) 2000-11-01
EP0501882B1 (de) 2000-07-12
GR3034509T3 (en) 2000-12-29
PL296623A1 (en) 1993-09-20
JPH05506459A (ja) 1993-09-22
EP0501882A2 (de) 1992-09-02
CA2081660A1 (en) 1992-09-02
UA40570C2 (uk) 2001-08-15
US5573767A (en) 1996-11-12
SK328092A3 (en) 1995-01-05
PT501882E (pt) 2000-12-29
JP3177246B2 (ja) 2001-06-18
DK0501882T3 (da) 2000-12-11
DE69231232D1 (de) 2000-08-17
EP0501882A3 (en) 1992-10-14
CA2081660C (en) 2001-05-01
HUT63338A (en) 1993-08-30
WO1992015330A1 (fr) 1992-09-17
DE69231232T2 (de) 2001-01-04
KR100257214B1 (ko) 2000-05-15
CZ328092A3 (en) 1993-10-13
IE920648A1 (en) 1992-09-09
SK282056B6 (sk) 2001-10-08
HU214453B (hu) 1998-03-30

Similar Documents

Publication Publication Date Title
ATE194625T1 (de) Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
KR937000146A (ko) 거세되지 않은 수컷 가축의 고기의 관능적 품질을 개선하기 위한 방법, 이 방법에 이용 가능한 백신, 특히 그 백신을 생산하기 위한 신규의 펩티드 및 그에 관계된 백신반응 키트
NO933126D0 (no) Loeselige ligander for cd40
MX9604907A (es) Vacuna de combinacion de virus para la enfermedad de newcastle.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
EP0464124A1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines säugetieres gegen lhrh und methode zur verbesserung von mea.
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
DE3867119D1 (de) Verfahren zum betaeuben von lungenatmenden schlachttieren.
ATE205219T1 (de) Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff
EP0547102A4 (de)
US20030104034A1 (en) Poultry feed supplement for increasing poultry-based meat weight
MX9207129A (es) Metodo para mejorar las cualidades organolepticas de la carne de animales domesticos sin castrar, vacunas que son utilizables en este metodo, nuevo peptido, en particular, para producir esas vacunas, y estuche de vacunacion relacionado con ello.
EP0839913A3 (de) Auf DNA beruhende Impfung von Fishen durch Wässerung
TW368393B (en) Poison bait for controlling noxious insects
CN1067551C (zh) 猪源抗鸡主要传染病高免血清的制备方法
DE59209270D1 (de) Rinderschlachtverfahren und Rinderschlachtanlage
RO100738A2 (ro) Procedeu de preparare a vaccinului inactivat uleios, contra bursitei infectioase aviare
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification